CHRISTOPHER DOOLIN: Open Payments
NPI 1699090514 · COLUMBIA, KY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$993 in 59 payments from 8 companies in 2025. Trend: 2023 $159 · 2024 $289 · 2025 $993
Food & beverage: $993
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 28 | $385 |
| Axsome Therapeutics, Inc. | 10 | $293 |
| Alkermes, Inc. | 11 | $138 |
| PFIZER INC. | 3 | $58 |
| Amgen Inc. | 2 | $35 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 2 | $34 |
| AstraZeneca Pharmaceuticals LP | 2 | $30 |
| Lilly USA, LLC | 1 | $20 |
Products named: Auvelity, VRAYLAR, QULIPTA, UBRELVY, LYBALVI, ARISTADA, NURTEC ODT, EVENITY.
Industry payments across KY — which companies pay providers there.
